The vascular access devices market is projected to expand from US$ 5.62 billion in 2022 to US$ 10.29 billion by 2030, reflecting a compound annual growth rate (CAGR) of 7.9% during this period.

Vascular access devices are utilized at various anatomical sites to reach the superior or inferior vena cava, including the internal jugular vein, subclavian vein, external jugular vein, and femoral vein. The anticipated growth in this market is primarily driven by the rising incidence of chronic illnesses and an increase in chemotherapy treatments. Furthermore, strategic initiatives undertaken by companies to maintain their competitive edge are also contributing to market expansion. The notable rise in AI-integrated robotic venous access devices is expected to introduce new trends in the vascular access devices market throughout the forecast period.

### Rising Incidence of Chronic Diseases Boosting Market Growth

Chronic conditions such as cardiovascular diseases, gastrointestinal disorders, rheumatoid arthritis, and neurological disorders significantly impact individuals' quality of life. The World Health Organization (WHO) estimates that approximately 50% of the global population is affected by at least one chronic disease. A comprehensive multinational study published in 2021, titled "Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study," revealed that around 40% of 73,076 adults surveyed across 33 countries reported suffering from a functional gastrointestinal disorder (GFID). Notably, age-related gastrointestinal issues are more prevalent among the elderly, particularly those aged 64 and older. A 2022 study, "Gastrointestinal problem among Indian adults: Evidence from Longitudinal Aging Study in India," indicated that self-reported gastrointestinal disorders had a prevalence of approximately 18%. This study also highlighted varying rates of gastrointestinal issues globally, ranging from 14% in Iran to as high as 54% in certain Western nations.

Cardiovascular diseases (CVDs), particularly those linked to modern lifestyles, are a leading cause of death worldwide. The International Diabetes Federation (IDF) reported that in 2021, 537 million individuals aged 20-79 were living with diabetes, with projections suggesting this number could rise to 783 million by 2045. Additionally, diabetes was responsible for 6.7 million deaths globally in 2021.

Aging is associated with a gradual decline in physiological integrity, leading to diminished functionality and an increased risk of mortality. This decline in bodily function is a significant risk factor for many chronic diseases, including diabetes, CVD, and neurological disorders, particularly among older adults. According to the WHO, by 2030, one in six individuals worldwide will be over the age of 60. The population aged 60 and above is expected to grow from 1 billion in 2020 to 1.4 billion by 2030. As the prevalence of chronic diseases rises alongside an aging population, the demand for drugs and nutrition delivered through the venous system is increasing, thereby driving the need for vascular access devices.

### Market Segmentation by Product Type

The vascular access devices market is categorized by product type into several segments: short peripheral intravenous catheters, midline catheters, peripherally inserted central catheters (PICC), central catheters, implantable ports, and accessories. Among these, the short peripheral intravenous catheter segment dominated the market in 2022 and is expected to exhibit the highest CAGR from 2022 to 2030.

### Application-Based Market Segmentation

In terms of application, the market is divided into drug administration, fluid and nutrition administration, blood product transfusion, and other uses. The drug administration segment held the largest market share in 2022 and is projected to achieve the highest CAGR during the forecast period.

### Route of Insertion Segmentation

The market is also segmented based on the route of insertion into subcutaneous and intravenous categories. The intravenous segment accounted for a larger share of the vascular access devices market in 2022 and is anticipated to experience a higher CAGR from 2022 to 2030.

### End User Segmentation

From the perspective of end users, the market is divided into hospitals and clinics, ambulatory surgical centers, and other facilities. The hospitals and clinics segment is expected to see significant growth in market size from 2022 to 2030.

### Geographic Market Segmentation

Geographically, the vascular access devices market is segmented into North America (including the US, Canada, and Mexico), Europe (covering the UK, Germany, France, Italy, Spain, Russia, and the rest of Europe), Asia Pacific (including China, Japan, India, South Korea, Australia, and the rest of Asia Pacific), the Middle East & Africa (comprising the UAE, Saudi Arabia, South Africa, and the rest of the region), and South & Central America (including Brazil, Argentina, and the rest of the region). North America is currently the largest contributor to the global vascular access devices market, while the Asia Pacific region is projected to exhibit the highest CAGR during the forecast period.

Key sources referenced in the preparation of this report include the World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA), and the National Library of Medicine (NLM).